(Q74626168)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9618799%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

review article

1 reference

title

Glucocorticoid-induced osteoporosis: prevention and treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9618799%20AND%20SRC:MED&resulttype=core&format=json

glucocorticoid-induced osteoporosis

12 November 2019

main subject

1 reference

R Ziegler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9618799%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

C Kasperk

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9618799%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 May 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9618799%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9618799%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9618799%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

344-348

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9618799%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

5-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9618799%20AND%20SRC:MED&resulttype=core&format=json

Recovery from steroid-induced osteoporosis

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2898%2900022-1

7 January 2021

Corticosteroid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2898%2900022-1

7 January 2021

Production, degradation, and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2898%2900022-1

7 January 2021

Bone histomorphometry in glucocorticoid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2898%2900022-1

7 January 2021

The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2898%2900022-1

7 January 2021

Calcium metabolism and osteoporosis in corticosteroid-treated postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2898%2900022-1

7 January 2021

Osteoporosis in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2898%2900022-1

7 January 2021

Inflammation-mediated osteopenia in the rat: a new animal model for pathological loss of bone mass

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2898%2900022-1

7 January 2021

Osteopenia in patients with rheumatic diseases: principles of diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2898%2900022-1

7 January 2021

In corticosteroid-treated respiratory diseases, monofluorophosphate increases lumbar bone density: a double-masked randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2898%2900022-1

7 January 2021

Bone loss after cardiac transplantation: effects of calcium, calcidiol and monofluorophosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2898%2900022-1

7 January 2021

Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2898%2900022-1

7 January 2021

Salmon calcitonin in the therapy of corticoid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2898%2900022-1

7 January 2021

Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma. A one-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2898%2900022-1

7 January 2021

Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2898%2900022-1

7 January 2021

Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2898%2900022-1

7 January 2021

Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2898%2900022-1

7 January 2021

Differential effects of glucocorticoids on human osteoblastic cell metabolism in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2898%2900022-1

7 January 2021

Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2898%2900022-1

7 January 2021

10.1016/S0039-128X(98)00022-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9618799%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference